Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.
From the intensifying battle over weight-loss drugs to the rise of AI to the uncertainty about President-elect Donald Trump's second term, biotech stocks won't be boring in 2025.
